Research Capital initiated coverage of Aleafia Health (TSX:AH) with a “buy” rating and price target of 75 cents (Canadian). The stock closed at 36 cents on Sept. 21. “We believe that Aleafia’s revenue growth will be...
Tag - Research Capital
